Biochemical Analysis of O-GlcNAcylation on α-Synuclein Aggregation, Cytotoxicity and Glycosylation Modification in Fibril-Seeding Neurons
Authors:
- Hongrui MengHMHongrui Meng
- Yongzhen MiaoYMYongzhen Miao
- Zhuoya MaZMZhuoya Ma
- Chun-Feng LiuCLChun-Feng Liu
Open Access
- 27 August 2026
- book chapter
- Published by IntechOpen
Abstract
The accumulation of amyloidogenic α-synuclein (α-syn) is the prominent marker of Lewy bodies, typically deposited in neurons in Parkinson’s disease (PD) and several other neurodegenerative disorders. Various posttranslational modifications (PTMs), such as O-GlcNAcylation, occur in α-syn. Modification by O-GlcNAcylation effectively hinders α-syn aggregation and attenuates its cellular toxicity in vitro and in vivo. Robust methods are crucial for investigating O-GlcNAc modification of α-syn and understanding its pivotal roles in intricate cellular processes and diseases. Here, we describe biochemical approaches for evaluating the effect of O-GlcNAc modification on the neuronal toxicity of α-syn aggregates and detecting this modification through an enzymatic labeling method. Employing an enzymatic labeling approach to investigate α-syn O-GlcNAcylation also involves attaching defined molecular weights of polyethylene glycol polymers to O-GlcNAcylated proteins. Mass tag installation causes the O-GlcNAcylated proteins to shift upward when separated by SDS-PAGE electrophoresis. The O-GlcNAcylated α-syn protein, with a predictable molecular weight, can be determined using immunoblotting with a specific antibody. This approach enables the identification and distinction of the O-GlcNAcylated and non-O-GlcNAcylated forms of α-syn proteins, thereby allowing the quantification of the conformational fibril α-syn proteins modified by O-GlcNAcylation. These methods may represent a useful strategy for analyzing the posttranslational O-GlcNAc modifications of α-syn protein in various samples.Keywords
This publication has 25 references indexed in Scilit:
- Expression and Purification of Untagged α-Synuclein2019
- Optimization of Chemoenzymatic Mass Tagging by Strain-Promoted Cycloaddition (SPAAC) for the Determination of O-GlcNAc Stoichiometry by Western BlottingBiochemistry, 2018
- Methods for the Detection, Study, and Dynamic Profiling of O-GlcNAc Glycosylation2018
- Post-translational modification of α-synuclein in Parkinson׳s diseaseBrain Research, 2015
- O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's diseaseNature Chemistry, 2015
- Spreading of pathology in neurodegenerative diseases: a focus on human studiesNature Reviews Neuroscience, 2015
- Nutrient Regulation of Signaling, Transcription, and Cell Physiology by O-GlcNAcylationCell Metabolism, 2014
- In Vitro Folding of β-1,4Galactosyltransferase and Polypeptide-α-N-Acetylgalactosaminyltransferase from the Inclusion Bodies2013
- α-Synuclein in Lewy bodiesNature, 1997
- Glycosylation of nuclear and cytoplasmic proteins. Purification and characterization of a uridine diphospho-N-acetylglucosamine:polypeptide beta-N-acetylglucosaminyltransferase.Journal of Biological Chemistry, 1992